MEXIDOL ® [Emoxypine]

Dosage and administration

The dug is taken orally, 125 - 250 mg 3 times a day, Maximum daily dose – 800 mg. Period of therapy is 2-6 weeks. Period of therapy for alcohol abstinence treatment is 5-7 days. Period of therapy for ischemic heart disease is 1,5 – 2 months or more.


Hypersensitivity to Mexidol, acute severe diseases of kidneys, hepatic liver failure.

Side effects

Allergic reaction


No overdose effect.

Drug Interactions

The drug potentiates the effect of energizers, anxiolytics, anticonvulsive drugs. It diminishes toxic effect of ethanol.

Country of Manufacture: Russia

You can read the full instruction here

US Domestic shipping is available for this product! Choose Ships from: US size option to get it in 3-7 days to any US address. Dont forget to choose US Domestic Shipping when checking out.

The development of Mexidol® is closely related to Soviet chemist Semenov N.N, who was awarded with the Nobel Prize in Chemistry for his piece of research on free radicals in 1956. His research was the basis for understanding of the oxidative stress and means to combat it. It also contributed to the development of drugs with antioxidant and anti-ischemic effects, one of which was Emoxypine, which is currently known as Mexidol®.

The drug has a positive effect on cellular energy production, as it diminishes the effect of free radicals and restores the activity of antioxidant enzymes. Mexidol ® also improves the intracellular protein synthesis, helps the enzyme processes in the citric acid cycle, and facilitates glycose utilization, as well as synthesis and intracellular storage of the ATP. This can prevent pathomorphological changes in the brain caused by ischemia and hypoxia.

Mexidol ® has the following effects: anti-ischemic, anti-hypoxic, neuroprotective, and anxiolytic. Many people report strong anxiolytic effects developed during the course of treatment with Mexidol ®.

Mexidol has been proven to be efficient when used for:

  • Acute Disorders of Cerebral Circulation
  • Traumatic Brain Injuries
  • Vegetative-Vascular Dystonia
  • Intoxication with Alcohol or Neuroleptic Drugs
  • Dysautonomia
  • Anxious disorders
  • Coronary Heart Disease
  • Asthenic Disorders of Different Types, e.g. Somatic Symptoms Disorders and Consequences of infections

Like Semax ® and Cerebrolysin ®, Mexidol ® is on the Russia’s List of Vital & Essential Drugs. It is also included in the first-aid kit in Russia, and has been in clinical practice since 1996.

In 2014 Mexidol ® received the Russian Pharma Award in the following categories: “Treatment if Ischemic Disorders” and “Treatment of Encephalopathy in Children”.

Country of Manufacture: Russia

Availability: in stock

Legal Disclaimer

This product has not been approved by the US FDA. All statements on this page are for informational purposes only and have not been evaluated by the US FDA.

This product is not intended to diagnose, treat, cure, or prevent any disease.

Type: Nootropics